Literature DB >> 9374891

Fortnightly review. A regular review of the long-term follow up of depression.

J Angst1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9374891      PMCID： PMC2127724          DOI： 10.1136/bmj.315.7116.1143

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.

Authors:  M Philipp; R Kohnen; K O Hiller
Journal:  BMJ       Date:  1999-12-11

2.  When to stop?

Authors:  Jon Eik Zwisler; John Larsen; Lars F Gram
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

3.  Absenteeism due to mental health problems and systems for return to work: an internet-based unmatched case-control study.

Authors:  Shotaro Doki; Shinichiro Sasahara; Yasuhito Hirai; Yuichi Oi; Ichiyo Matsuzaki
Journal:  Int Arch Occup Environ Health       Date:  2016-08-22       Impact factor: 3.015

4.  Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

Authors:  Robin B Jarrett; Abu Minhajuddin; Howard Gershenfeld; Edward S Friedman; Michael E Thase
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

5.  Evaluation of a system of structured, pro-active care for chronic depression in primary care: a randomised controlled trial.

Authors:  Marta Buszewicz; Mark Griffin; Elaine M McMahon; Jennifer Beecham; Michael King
Journal:  BMC Psychiatry       Date:  2010-08-04       Impact factor: 3.630

6.  Structured pro-active care for chronic depression by practice nurses in primary care: a qualitative evaluation.

Authors:  Madeleine Bennett; Kate Walters; Vari Drennan; Marta Buszewicz
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

7.  A survey of support systems for return to work in Japanese companies: a cross-sectional study.

Authors:  Shotaro Doki; Shinichiro Sasahara; Yuichi Oi; Ichiyo Matsuzaki
Journal:  Ind Health       Date:  2016-05-14       Impact factor: 2.179
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.